Cairn Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,951
Closed -$201K 71
2024
Q3
$201K Buy
+6,951
New +$203K 0.11% 67
2024
Q1
Sell
-6,951
Closed -$200K 67
2023
Q4
$200K Sell
6,951
-372
-5% -$11.2K 0.12% 64
2023
Q3
$243K Buy
7,323
+372
+5% +$13.2K 0.16% 57
2023
Q2
$255K Sell
6,951
-21,971
-76% -$855K 0.17% 59
2023
Q1
$1.18M Sell
28,922
-310
-1% -$13.4K 0.82% 38
2022
Q4
$1.5M Buy
29,232
+1,440
+5% +$69K 1.12% 32
2022
Q3
$1.22M Sell
27,792
-1,550
-5% -$75.3K 0.98% 32
2022
Q2
$1.54M Buy
29,342
+6,521
+29% +$332K 1.2% 30
2022
Q1
$1.78M Buy
22,821
+870
+4% +$45.1K 1.13% 34
2021
Q4
$1.3M Sell
21,951
-3,060
-12% -$152K 0.89% 37
2021
Q3
$1.07M Sell
25,011
-125
-0.5% -$5.54K 0.8% 41
2021
Q2
$984K Sell
25,136
-1,460
-5% -$56.8K 0.72% 43
2021
Q1
$964K Sell
26,596
-2,180
-8% -$77.4K 0.8% 42
2020
Q4
$1.06M Sell
28,776
-1,174
-4% -$43.1K 1% 37
2020
Q3
$1.04M Sell
29,950
-2,867
-9% -$101K 1.1% 35
2020
Q2
$1.02M Sell
32,817
-3,278
-9% -$111K 1.24% 35
2020
Q1
$1.12M Sell
36,095
-3,629
-9% -$124K 1.66% 27
2019
Q4
$1.48M Buy
+39,724
New +$1.41M 1.46% 30

Other funds holding PFE

Cairn Investment Group's PFE Position: Q4 2024 in Review

Cairn Investment Group sold out of Pfizer (PFE) in Q4 2024, closing a stake of 6,951 shares — an estimated $201K sold.

Cairn Investment Group first reported a position in PFE in Q4 2019 and held it in 18 quarters. The position peaked at $1.78M in Q1 2022. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Cairn Investment Group reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Cairn Investment Group sold 6,951 Pfizer shares in Q4 2024, an estimated $201K.
  • Cairn Investment Group first reported a position in Pfizer in Q4 2019 and held it in 18 quarters.
  • Cairn Investment Group's Pfizer position peaked at $1.78M in Q1 2022.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Cairn Investment Group's 13F filing for Q4 2024, filed 23 Jan 2025.